154 related articles for article (PubMed ID: 26871713)
21. Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas.
Roswarski J; Roschewski M; Lucas A; Melani C; Pittaluga S; Jaffe ES; Steinberg SM; Waldmann TA; Wilson WH
Leuk Lymphoma; 2018 Jun; 59(6):1466-1469. PubMed ID: 29032710
[No Abstract] [Full Text] [Related]
22. [A case report of composite lymphoma].
Wu J; Wang ZC; Chen XD
Ai Zheng; 2007 Apr; 26(4):447. PubMed ID: 17430672
[No Abstract] [Full Text] [Related]
23. Peripheral T-cell lymphoma with unusual clinical presentation of rhabdomyolysis.
Liu Z; Medeiros LJ; Young KH
Hematol Oncol; 2017 Mar; 35(1):125-129. PubMed ID: 25921311
[TBL] [Abstract][Full Text] [Related]
24. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
Marzolini M; Wong WL; Ardeshna K; Padhani A; D'Sa S
Br J Haematol; 2012 Mar; 156(5):557. PubMed ID: 22150023
[No Abstract] [Full Text] [Related]
25. T-cell lymphoma manifesting as a uvular mass.
Lai WS; Wang CH; Shih CP
Rheumatology (Oxford); 2013 Apr; 52(4):608. PubMed ID: 23264553
[No Abstract] [Full Text] [Related]
26. [Clinical features and prognostic factors of angioimmunoblastic T cell lymphoma].
Qin Y; Shi YK; He XH; Yang JL; Zhang CG; Zhou SY; Liu XF; Liu P; Yang S; Zhou LQ; Han XH; Yao JR
Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):448-51. PubMed ID: 20819488
[TBL] [Abstract][Full Text] [Related]
27. [Recent advance in peripheral T-cell lymphoma, not otherwise specified].
Duan R; Zhang JZ
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):427-9. PubMed ID: 21055168
[No Abstract] [Full Text] [Related]
28. Posterior reversible encephalopathy syndrome (PRES) complicating newly-diagnosed diffuse large B-cell lymphoma.
Sengupta S; Benkers T; Blitstein M; Palmer E; Plotkin SR; Abramson JS
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e111-3. PubMed ID: 24581553
[No Abstract] [Full Text] [Related]
29. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
[TBL] [Abstract][Full Text] [Related]
30. Results of a phase III clinical trial: CHOP versus CMED in peripheral T-cell lymphoma unspecified.
Avilés A; Castañeda C; Neri N; Cleto S; Talavera A; González M; Huerta-Guzmán J; Nambo MJ
Med Oncol; 2008; 25(3):360-4. PubMed ID: 18247163
[TBL] [Abstract][Full Text] [Related]
31. Subcutaneous panniculitis-like T-cell lymphoma with extracutaneous dissemination demonstrated on FDG PET/CT.
Babb A; Zerizer I; Naresh KN; Macdonald D
Am J Hematol; 2011 Apr; 86(4):375-6. PubMed ID: 21442643
[No Abstract] [Full Text] [Related]
32. Rosai Dorfman disease and peripheral T-cell lymphoma: A rare co-occurrence.
Tiwari V; Pareek A; Ghori H; Ahirwar M
J Postgrad Med; 2019; 65(1):62-63. PubMed ID: 30464074
[No Abstract] [Full Text] [Related]
33. High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
Kedmi M; Apel A; Davidson T; Levi I; Dann EJ; Polliack A; Ben-Bassat I; Nagler A; Avigdor A
Acta Haematol; 2016; 135(3):156-61. PubMed ID: 26588173
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary manifestations of peripheral T-cell lymphoma: case report and review of the literature.
Vahid B; Machare-Delgado E; Marik PE
Clin Respir J; 2007 Dec; 1(2):114-7. PubMed ID: 20298290
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.
Pellegrini C; Argnani L; Broccoli A; Stefoni V; Derenzini E; Gandolfi L; Casadei B; Maglie R; Pileri S; Zinzani PL
Oncologist; 2014 Jul; 19(7):746-50. PubMed ID: 24869930
[TBL] [Abstract][Full Text] [Related]
36. [Epstein-Barr virus-positive diffuse large B-cell lymphoma following peripheral T-cell lymphoma, not otherwise specified: report of a case].
Zhang F; Liu YH; Zhuang HG; Li L; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):414-5. PubMed ID: 21055162
[No Abstract] [Full Text] [Related]
37. A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
Dann EJ; Blumenfeld Z; Bar-Shalom R; Avivi I; Ben-Shachar M; Goor O; Libster D; Gaitini D; Rowe JM; Epelbaum R
Am J Hematol; 2012 Jan; 87(1):32-6. PubMed ID: 21956220
[TBL] [Abstract][Full Text] [Related]
38. Primary bone lymphoma involving bilateral tibia.
Giardino AA; Shinagare AB; Shinagare SA; Dewar R; Weckstein D; Mauch P; Ramaiya NH; Freedman AS
Am J Hematol; 2012 Sep; 87(9):924-5. PubMed ID: 22641233
[No Abstract] [Full Text] [Related]
39. [Evaluation Value of Invasion Area PET-CT Scanning for Chemotherapeutic Efficacy and Prognosis of Patients with Lymphoma].
Wang J; Pang H; Jing XG; Duan D; Xu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):106-9. PubMed ID: 26913404
[TBL] [Abstract][Full Text] [Related]
40. Drug-induced eosinophilia and systemic symptoms: hypersensitivity or peripheral T-cell lymphoma?
Schleinitz N; Veit V; Coso D; Aurran T; Berbis P; Harle JR
Arch Dermatol; 2005 Mar; 141(3):395-6. PubMed ID: 15781686
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
